The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines

BACKGROUND: Therapeutic tumor vaccines are one of the most promising strategies and have attracted great attention in cancer treatment. However, most of them have shown unsatisfactory immunogenicity, there are still few available vaccines for clinical use. Therefore, there is an urgent demand to dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yonghui, Wang, Zhaoyu, Yu, Fan, Li, Mingjing, Zhu, Haomiao, Wang, Kun, Meng, Meng, Zhao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813472/
https://www.ncbi.nlm.nih.gov/pubmed/33469292
http://dx.doi.org/10.2147/IJN.S273883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813472/
https://www.ncbi.nlm.nih.gov/pubmed/33469292
http://dx.doi.org/10.2147/IJN.S273883

Ejemplares similares